Efficacy of azythromicin-based triple therapy for Helicobacter pylori infection: A retrospective study

Panminerva Medica

Volumn 50, Issue 3, 2008, Pages 259-260

  Pellicano, R ^a   Astegiano, M ^a   Smedile, A ^a   Saracco, G ^a   Berrutti, M ^a   Strona, S ^a   Fadda, M ^a   Repici, A ^b   Fagoonee, S ^c   Rizzetto, M ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; CLARITHROMYCIN; PROTON PUMP INHIBITOR;

ADULT; AGED; COMPARATIVE STUDY; DRUG COMBINATION; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LETTER; MALE; MICROBIOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 57349179952     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (11)

1. Liu Y, Akiyama J, Graham DY. Current understandings of Helicobacter pylori, peptic ulcer and gastroesophageal reflux disease. Minerva Gastroenterol Dietol 2006;52:235-48.
2. Testino G. Gastric precancerous changes: carcinogenesis, clinical behaviour immunophenotype study and surveillance. Panminerva Medica 2006;48:109-18.
3. Pellicano R, Peyre S, Astegiano M, Oliaro E, Fagoonee S, Rizzetto M. Updated review (2006) on Helicobacter pylori as a potential target for the therapy of ischemic heart disease. Panminerva Med 2006;48:241-6.
4. Malfertheiner P, Mégraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-81.
5. Klotz U. Pharmacokinetic considerations in the eradication of Helicobacter pylori. Clin Pharmacokinet 2000;38:243-70.
6. Pellicano R, Bonardi R, Smedile A, Saracco G, Ponzetto A, Lagget M et al. Gastroenterology outpatient clinic of the Molinette Hospital (Turin, Italy): the 2003-2006 report. Minerva Med. 2007;98:19-23.
7. Palmas F, Pellicano R, Massimetti E, Berrutti M, Fagoonee S, Rizzetto M. Eradication of Helicobacter pylori infection with proton pump inhibitor-based triple therapy. A randomised study. Panminerva Med 2002;44:145-7.
8. Pellicano R, Smedile A, Ponzetto A, Berrutti M, Astegiano M, Saracco G et al. How accurate is the culture of Helicobacter pylori in a clinical setting? An appraisal. Panminerva Medica 2005;47:191-4.
9. Sullivan B, Coyle W, Nemec R, Dunteman. Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori. Am J Gastroenterol 2002;97:2536-9.
10. Laurent J, Mégraud F, Fléjou JF, Caekaert A, Barthélemy P. A randomized comparison of four omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther 2001;15:1787-93.
11. Silva FM, Eisig JN, Teixeira ACS, Barbuti RC, Navarro-Rodriguez T, Mattar R. Short-term triple therapy with azithromycin for Helicobacter pylori eradication: low cost, high compliance, but low efficacy. BMC Gastroenterol 2008;8:20.